SEC Form 4 · accession 0001645627-17-000136
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Nov 3, 2017
Accepted (ET)
Nov 7, 2017 · 1:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 3, 2017 | P | 3,000 | $0.064 | A | 24,084,189 | D | |
| Common Stock | Nov 3, 2017 | P | 2,000 | $0.063 | A | 24,086,189 | D | |
| Common Stock | Nov 3, 2017 | P | 3,000 | $0.063 | A | 24,089,189 | D | |
| Common Stock | Nov 3, 2017 | P | 3,000 | $0.0625 | A | 24,092,189 | D | |
| Common Stock | Nov 3, 2017 | P | 3,000 | $0.0612 | A | 24,095,189 | D | |
| Common Stock | Nov 6, 2017 | P | 3,000 | $0.0596 | A | 24,098,189 | D | |
| Common Stock | Nov 6, 2017 | P | 3,000 | $0.0599 | A | 24,101,189 | D | |
| Common Stock | Nov 6, 2017 | P | 3,000 | $0.061 | A | 24,104,189 | D | |
| Common Stock | Nov 6, 2017 | P | 3,000 | $0.0607 | A | 24,107,189 | D | |
| Common Stock | Nov 6, 2017 | P | 3,000 | $0.061 | A | 24,110,189 | D | |
| Common Stock | Nov 6, 2017 | P | 2,000 | $0.0574 | A | 24,112,189 | D | |
| Common Stock | Nov 6, 2017 | P | 2,000 | $0.0575 | A | 24,114,189 | D | |
| Common Stock | Nov 6, 2017 | P | 2,000 | $0.0575 | A | 24,116,189 | D | |
| Common Stock | Nov 6, 2017 | P | 2,000 | $0.0577 | A | 24,118,189 | D |
Table II — derivative securities
No Table II lines on this filing.